Phacilitate Leaders Forum: Oncology & R&D

Click here for the pdf version of our workshop where we addressed the issue of “going global” for oncology trials – is it a pathway to the “Holy Grail” of faster – cheaper – better?


Wednesday, October 29, 2008

Strategic considerations for global oncology studies: Recruitment, retention, vendor management & quality

Panelists:

Evette Riegel, RN
Director, Clinical Operations

Arthur Gertel, MS
VP, Clinical Services, Regulatory & Medical Writing
Beardsworth Consulting Group, Inc.

  • Recent FDA interaction with FDA on percentage of US patients in registration trials
  • Data quality, and Standard- of-Care considerations for global programs
  • Impact of study start-up & close-out timelines that influence country selection
  • Perception versus reality – oncology case study experience


    • The San Diego Leaders’ Forum 2008, provides a high-level meeting place for senior figures driving the development, approval and launch of novel cancer therapies of all classes. The program features over 40 speakers representing oncology therapeutic developers, the regulators and sector analysts. A selection of discussion and workshop sessions will ensure maximum interaction between all participants, and superb networking opportunities will compliment the program itself.

    Visit the Phacilitate web site at http://www.phacilitate.co.uk/leaders

    Return to Upcoming Events
    ©2006 Beardsworth Consulting Group, Inc. All rights reserved.
    The Path Logo is a trademark of Beardsworth Consulting Group, Inc.